Table 5.
The clinicopathological relevance analysis of CXCL12+ TAMs number in HCC patients
| High (N=17) | Low (N=18) | P-value* | |
|---|---|---|---|
| Gender | |||
| Female | 4 (23.5%) | 6 (33.3%) | 0.789 |
| Male | 13 (76.5%) | 12 (66.7%) | |
| Age | |||
| ≥50 | 15 (88.2%) | 13 (72.2%) | 0.447 |
| <50 | 2 (11.8%) | 5 (27.8%) | |
| Capsule | |||
| No | 12 (70.6%) | 12 (66.7%) | 1 |
| Yes | 5 (29.4%) | 6 (33.3%) | |
| Vessel | |||
| No | 12 (70.6%) | 17 (94.4%) | 0.155 |
| Yes | 5 (29.4%) | 1 (5.6%) | |
| Child-Pugh stage | |||
| classA | 12 (70.6%) | 15 (83.3%) | 0.621 |
| classB | 5 (29.4%) | 3 (16.7%) | |
| HbsAg | |||
| Negative | 5 (29.4%) | 5 (27.8%) | 1 |
| Positive | 12 (70.6%) | 13 (72.2%) | |
| Cirrhosis | |||
| S0 | 0 (0%) | 8 (44.4%) | 0.0035 |
| S1 | 3 (17.6%) | 9 (50.0%) | |
| S2 | 4 (23.5%) | 4 (22.2%) | |
| S3 | 2 (11.7%) | 3 (16.7%) | |
| S4 | 8 (47.1%) | 1 (5.6%) | |
| AFP | |||
| Abnormal | 9 (52.9%) | 6 (33.3%) | 0.407 |
| Normal | 8 (47.1%) | 12 (66.7%) | |
| TNM | |||
| I | 3 (17.6%) | 12 (66.7%) | 0.012 |
| II | 10 (58.8%) | 5 (27.8%) | |
| III | 4 (23.5%) | 1 (5.6%) |
*
Data was analyzed by chi-squared test.
P value in bold indicated statistically significant.